Inter-patient variability in established epithelial BC marker genes (EPCAM, KRT8, KRT18, KRT19 and TRPS1) was minimally impacted by receptor status but notably by profiling method (Fig. 2g). The gene discussed is KRT8; the disease is breast cancer.